This study aims to assess the safety and clinical accuracy of the SIRA-1000, SIRA® RFA Electrosurgical Device in ablating margins post-lumpectomy in patients u…

Breast CancerBreast-conserving SurgeryBreast Cancer - Infiltrating Ductal Carcinoma+2 more

~Estimated

~$10 – $8,750

Innoblative Designs, Inc.NCT07206121

Phase 2

Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

The usual approach to care for hormone receptor positive, HER2 positive breast cancer is chemotherapy and HER2 targeted therapy followed by endocrine therapy a…

Breast Cancer - Infiltrating Ductal CarcinomaHER-2 Positive Breast Cancer

~Estimated

~$10 – $6,250

Legacy Health SystemNCT07506876